Back to search
FDAFDA · Food and drugs·Recall number D-1064-2014

Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titration pack,Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3400-29.

Published February 12, 2014 · Recall initiated: November 13, 2013

Summary

FDA records drug Class III recall D-1064-2014, published February 12, 2014 and initiated November 13, 2013. Recalling firm: Forest Pharmaceuticals Inc; Status: Terminated; Reported quantity: 3,950 packs; Lot: Lot 1113661 Exp. 01/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Forest Pharmaceuticals Inc
Distributor
Nationwide and Puerto Rico.
Lot
Lot 1113661 Exp. 01/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titration pack,Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3400-29. recalled?

Yes. FDA published recall D-1064-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter